This 7-week webinar series organised by XtalPi and J-STAR starts 7th April 2021.

For busy professionals working in pharmaceutical solid form, we have created a 7-week webinar series to distil state-of-the-art solutions to key challenges. Each webinar will feature a leading expert who understands your daily workflow and will share his/her real-world experience in successfully supporting preclinical and clinical projects.

The series will catalyze discussions aimed at ensuring a stable form is selected with optimal bioavailability and manufacturing properties.

APRIL 7, 2021 Correlation of Drug Substance Bulk Properties to Predict and Troubleshoot the Formulation of Drug Product
Dr. Henry Morrison, Senior Research Scientist II, Gilead Sciences, United States

APRIL 14, 2021 Importance of Solid Form, Formulation and Bioavailability during R&D
Dr. Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, United States

APRIL 21, 2021 Solid State Modeling and Its Role in Drug Development
Dr. Luca Iuzzolino, Computational Research Scientist, Merck, United States

APRIL 28, 2021 Amorphous Formulations for Solubility Enhancement: Risks and Opportunities
Dr. Daniel Joseph Price, Strategic Marketing Manager, Millipore Sigma, Germany

MAY 5, 2021 Current Practice and Future Perspective in Crystallography for API Solid Form Risk-Management
Dr. Luca Russo, GSK Fellow, GlaxoSmithKline, United Kingdom

MAY 12, 2021 Application of 15N SSNMR to Differentiate and Quantify Different API Amorphous Phases in Complex Tablet Formulation
Dr. Ales Medek, Research Fellow, Vertex, United States

MAY 19, 2021 Crystallisation in Agrochemicals: the Good, the Bad and the Unusual
Dr. Adam Keates, Specialist Particle Scientist, Syngenta, United Kingdom

Event Moderator: Dr. Sivakumar Sekharan, Senior Director of Business Development, XtalPi Inc., United States

To register please click here: